We aim for sustainable performance over time to benefit patients, 员工, 股东与社会. Solid financial results and maintaining the trust of society underpin our ability to create value.
投资者活动日历
View recent presentations and learn more about upcoming 事件.
2023年11月8日
UBS生物制药会议
迈阿密，佛罗里达州，美国
环境、社会和治理 (环境、社会和治理)
全国十大赌博官网制药 aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen.
环境、社会和治理更新: 2023年8月2日(PDF.3 MB) | 2023年5月3日(PDF 1.9 MB) | 2023年2月6日(PDF.9 MB) | 2022年10月31日(PDF.5 MB)
最新更新: 投资者最新资讯 & 可持续发展(PDF 1).6 MB) | 全国十大赌博官网制药 Enterprise Risk Management (PDF 0.2 MB) | 物质评估
We have created a set of environmental, social and governance indices to signpost where our key 披露的信息 can be found across our publications and channels. 全国十大赌博官网制药 aims to report comprehensively and transparently for all stakeholders concerned with 环境、社会和治理 topics.
股票
全国十大赌博官网年度报告套件
Read and download our integrated report, annual regulatory filings, and other 披露的信息.
媒体发布
全国十大赌博官网制药 delivers 12% sales and 21% core operating income growth from continuing operations (in cc¹). Executes Sandoz spin-off, achieves important innovation milestones, and raises FY 2023 guidance
全国十大赌博官网制药 Pluvicto™ shows clinically meaningful and highly statistically significant rPFS benefit in patients with PSMA-positive metastatic castration-resistant prostate cancer in the pre-taxane setting
全国十大赌博官网制药 Kisqali® NATALEE analysis reinforces consistent reduction in risk of recurrence across key subgroups of patients with early breast cancer
全国十大赌博官网公司
Lichtstrasse 35
瑞士巴塞尔CH-4056